As Inphi (IPHI) Market Valuation Declined, Holder J Goldman & Company LP Has Decreased Its Stake by $12.34 Million; Johnson & Johnson (JNJ) Shareholder Pennsylvania Trust Co Has Cut Stake

Inphi Corporation (NYSE:IPHI) Logo

Pennsylvania Trust Co decreased its stake in Johnson & Johnson (JNJ) by 1.35% based on its latest 2017Q4 regulatory filing with the SEC. Pennsylvania Trust Co sold 5,785 shares as the company’s stock declined 9.21% with the market. The institutional investor held 422,696 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $59.07 million, down from 428,481 at the end of the previous reported quarter. Pennsylvania Trust Co who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $344.10 billion market cap company. The stock increased 0.20% or $0.26 during the last trading session, reaching $128.27. About 4.27 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 28, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

J Goldman & Company Lp decreased its stake in Inphi Corp (IPHI) by 92.14% based on its latest 2017Q4 regulatory filing with the SEC. J Goldman & Company Lp sold 342,691 shares as the company’s stock declined 21.51% with the market. The hedge fund held 29,217 shares of the semiconductors company at the end of 2017Q4, valued at $1.07 million, down from 371,908 at the end of the previous reported quarter. J Goldman & Company Lp who had been investing in Inphi Corp for a number of months, seems to be less bullish one the $1.25 billion market cap company. The stock increased 1.47% or $0.42 during the last trading session, reaching $28.97. About 441,996 shares traded. Inphi Corporation (NYSE:IPHI) has declined 35.04% since April 28, 2017 and is downtrending. It has underperformed by 46.59% the S&P500.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity.

Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It is positive, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Murphy Pohlad Asset Management Limited Liability Company, a Minnesota-based fund reported 20,137 shares. Miller Investment Mgmt LP reported 17,828 shares. Hikari Tsushin owns 53,810 shares. West Chester Capital Advsrs Inc invested in 18,257 shares or 2.47% of the stock. Trillium Asset Mgmt Limited Liability Com owns 0.53% invested in Johnson & Johnson (NYSE:JNJ) for 68,478 shares. Inr Advisory Ser Limited Liability Company holds 0.01% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 584 shares. Cap City Tru Fl invested 2.22% in Johnson & Johnson (NYSE:JNJ). Burgundy Asset Mgmt Limited invested in 3.15 million shares or 4% of the stock. Independent Franchise Partners Llp, a United Kingdom-based fund reported 6.38M shares. Yorkville Capital Management Llc holds 1.01% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 6,000 shares. 5,748 are held by Wealth Architects Limited Liability Corporation. Wallington Asset Mgmt Ltd has 90,540 shares for 3.25% of their portfolio. 11,775 are owned by Winch Advisory Ltd Liability Co. Rothschild Asset Mngmt Inc accumulated 0.71% or 482,070 shares. Oregon Employees Retirement Fund owns 1.21% invested in Johnson & Johnson (NYSE:JNJ) for 575,107 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Societe Generale on Wednesday, April 6. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. Goldman Sachs downgraded Johnson & Johnson (NYSE:JNJ) rating on Wednesday, September 20. Goldman Sachs has “Sell” rating and $130.0 target. The firm has “Overweight” rating given on Wednesday, April 20 by Barclays Capital. Credit Suisse maintained Johnson & Johnson (NYSE:JNJ) on Thursday, October 19 with “Buy” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Monday, March 14 by Goldman Sachs. Citigroup maintained Johnson & Johnson (NYSE:JNJ) rating on Monday, October 23. Citigroup has “Buy” rating and $149 target. Jefferies maintained it with “Buy” rating and $170.0 target in Tuesday, January 16 report. The company was maintained on Wednesday, April 20 by Argus Research. The firm has “Buy” rating by Wells Fargo given on Tuesday, February 6.

Pennsylvania Trust Co, which manages about $2.24 billion US Long portfolio, upped its stake in Union Pac Corp (NYSE:UNP) by 4,760 shares to 156,310 shares, valued at $20.96M in 2017Q4, according to the filing. It also increased its holding in Teva Pharmaceutical Inds Ltd (NYSE:TEVA) by 27,200 shares in the quarter, for a total of 126,600 shares, and has risen its stake in Keycorp New (NYSE:KEY).

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.30, from 0.85 in 2017Q3. It improved, as 18 investors sold IPHI shares while 53 reduced holdings. 25 funds opened positions while 57 raised stakes. 50.71 million shares or 4.56% more from 48.49 million shares in 2017Q3 were reported. Putnam Invests Ltd Liability Company invested in 34,700 shares or 0% of the stock. Scout Invests reported 0.06% in Inphi Corporation (NYSE:IPHI). Royal Natl Bank Of Canada invested in 0.01% or 764,070 shares. Polar Cap Ltd Liability Partnership accumulated 0.03% or 88,930 shares. Eventide Asset Management Lc holds 555,000 shares or 1.06% of its portfolio. Moreover, Rothschild Inv Il has 0.11% invested in Inphi Corporation (NYSE:IPHI). Td Asset Mgmt accumulated 0% or 10,900 shares. Jefferies Grp invested in 0.01% or 33,340 shares. Stephens Invest Gru Limited Company owns 210,674 shares. Gilder Gagnon Howe Llc reported 202,293 shares. Granahan Investment Mgmt Inc Ma has invested 0.1% in Inphi Corporation (NYSE:IPHI). First Personal Fin has invested 0.01% in Inphi Corporation (NYSE:IPHI). Pnc Fincl Group holds 0% or 909 shares in its portfolio. 6,240 were reported by Proshare Ltd Liability. Clearbridge Investments Ltd has invested 0.06% in Inphi Corporation (NYSE:IPHI).

J Goldman & Company Lp, which manages about $1.17 billion and $1.84B US Long portfolio, upped its stake in Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) by 81,504 shares to 266,479 shares, valued at $5.05M in 2017Q4, according to the filing. It also increased its holding in Fedex Corp (NYSE:FDX) by 5,992 shares in the quarter, for a total of 68,492 shares, and has risen its stake in New Oriental Ed & Tech Grp I (NYSE:EDU).

Since January 3, 2018, it had 1 buy, and 6 sales for $2.85 million activity. Torten Ron sold 179 shares worth $6,786. The insider EDMUNDS JOHN sold 108,554 shares worth $2.74 million. SRINIVASAN SAM had bought 5,000 shares worth $124,650 on Friday, February 16.

Inphi Corporation (NYSE:IPHI) Institutional Positions Chart